Key regions: Australia, Brazil, United Kingdom, Europe, Canada
The Other Vaccines market in EU-27 is a dynamic and evolving market that has seen significant growth in recent years.
Customer preferences: Customers in the EU-27 region have shown a growing demand for Other Vaccines due to the increasing prevalence of infectious diseases. The demand for Other Vaccines is particularly high in countries with large populations and high population densities, as these areas are more susceptible to outbreaks of infectious diseases. Additionally, customers in the region are increasingly aware of the importance of vaccination and are taking proactive steps to protect themselves and their families.
Trends in the market: The Other Vaccines market in EU-27 is characterized by several key trends. Firstly, there is a growing trend towards the development of new and innovative vaccines that are more effective and have fewer side effects. This trend is being driven by advances in technology and research, as well as by increasing demand from customers for more effective vaccines. Secondly, there is a trend towards the use of combination vaccines, which offer protection against multiple diseases in a single shot. This trend is being driven by the convenience and cost-effectiveness of combination vaccines, as well as by the increasing prevalence of diseases that require multiple vaccinations. Finally, there is a trend towards the use of vaccines for non-infectious diseases, such as cancer and autoimmune disorders. This trend is being driven by advances in research and technology, as well as by increasing demand from customers for more effective treatments for these diseases.
Local special circumstances: The Other Vaccines market in EU-27 is characterized by several local special circumstances. Firstly, there are significant differences in vaccination rates between countries, with some countries having much higher rates than others. This is due to differences in healthcare systems, education, and cultural attitudes towards vaccination. Secondly, there are significant differences in the types of diseases that are prevalent in different countries, which affects the demand for different types of vaccines. For example, some countries have high rates of infectious diseases such as tuberculosis and hepatitis, while others have high rates of non-infectious diseases such as cancer and diabetes.
Underlying macroeconomic factors: The Other Vaccines market in EU-27 is influenced by several underlying macroeconomic factors. Firstly, there is a growing trend towards universal healthcare coverage in many countries, which is increasing access to vaccines for a larger proportion of the population. Secondly, there is increasing investment in research and development by both public and private organizations, which is driving the development of new and innovative vaccines. Finally, there is increasing government support for vaccination programs, which is driving demand for vaccines and increasing the availability of vaccines to customers.
Data coverage:
Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.Modeling approach / Market size:
Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
